,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.1,Off label use,16914233,
0,22.1,Chronic obstructive pulmonary disease,16914376,
0,22.1,Drug ineffective,16914663,
1,22.1,Malignant neoplasm progression,16914663,
0,22.1,Abdominal distension,16915736,
1,22.1,Drug ineffective,16915736,
2,22.1,Dizziness,16915736,
3,22.1,Nausea,16915736,
4,22.1,Malignant neoplasm progression,16915736,
0,22.1,Night sweats,16917812,
1,22.1,Chills,16917812,
2,22.1,Hot flush,16917812,
3,22.1,Decreased appetite,16917812,
4,22.1,Dysgeusia,16917812,
0,22.1,Confusional state,16918040,
1,22.1,Dehydration,16918040,
0,22.1,Tinnitus,16918254,
0,22.1,Fatigue,16918534,
1,22.1,Nausea,16918534,
2,22.1,Inappropriate schedule of product administration,16918534,
3,22.1,Gastrooesophageal reflux disease,16918534,
0,22.1,Haematemesis,16918673,
1,22.1,Therapy cessation,16918673,
0,22.1,Therapy cessation,16918744,
1,22.1,Haematemesis,16918744,
0,22.1,Cerebrovascular accident,16919263,
1,22.1,Blood pressure increased,16919263,
0,22.1,Diarrhoea,16919448,
0,22.1,Death,16919642,
0,22.1,Gout,16919688,
0,22.1,Urinary tract infection bacterial,16919777,
1,22.1,Pneumonia,16919777,
0,22.1,Intra-abdominal fluid collection,16919852,
1,22.1,Inflammation,16919852,
2,22.1,Malaise,16919852,
0,22.1,Headache,16920200,
1,22.1,Chills,16920200,
2,22.1,Pruritus,16920200,
3,22.1,Therapy cessation,16920200,
0,22.1,Amnesia,16920213,
0,22.1,Incorrect product administration duration,16920282,
1,22.1,Product communication issue,16920282,
0,22.1,Asthenia,16920368,
1,22.1,Heart rate decreased,16920368,
2,22.1,Dizziness,16920368,
0,22.1,Bone pain,16920375,
1,22.1,Abdominal pain lower,16920375,
2,22.1,Abdominal pain upper,16920375,
3,22.1,Splenic rupture,16920375,
4,22.1,Musculoskeletal pain,16920375,
0,22.1,Hypoaesthesia,16920432,
0,22.1,Pruritus,16920439,
1,22.1,Cough,16920439,
2,22.1,Blood count abnormal,16920439,
0,22.1,Muscle twitching,16920442,
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,16920442,
0,22.1,Pain in extremity,16920520,
0,22.1,Fall,16920559,
1,22.1,Seizure,16920559,
0,22.1,Fluid retention,16920562,
1,22.1,Inflammation,16920562,
0,22.1,Metastases to central nervous system,16920567,
0,22.1,Unevaluable event,16923066,
0,22.1,Fatigue,16923166,
1,22.1,Chills,16923166,
2,22.1,Diarrhoea,16923166,
3,22.1,Decreased appetite,16923166,
4,22.1,Asthenia,16923166,
5,22.1,Abdominal pain upper,16923166,
0,22.1,Diarrhoea,16923170,
1,22.1,Hypokalaemia,16923170,
2,22.1,Vomiting,16923170,
3,22.1,Dehydration,16923170,
4,22.1,Therapy cessation,16923170,
5,22.1,Nausea,16923170,
0,22.1,Oesophageal dilatation,16923438,
1,22.1,Gastric ulcer,16923438,
0,22.1,Rash,16923529,
1,22.1,Abdominal pain upper,16923529,
2,22.1,Diarrhoea haemorrhagic,16923529,
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,16923622,
1,22.1,Blister,16923622,
0,22.1,Stomatitis,16923732,
0,22.1,Blister,16923855,
1,22.1,Skin discolouration,16923855,
0,22.1,Decreased appetite,16924170,
1,22.1,Rash,16924170,
0,22.1,Death,16924266,
0,22.1,Stomatitis,16924833,
0,22.1,Abdominal pain upper,16924862,
0,22.1,Depressed level of consciousness,16924882,
1,22.1,Muscle spasms,16924882,
2,22.1,Endometrial cancer,16924882,
3,22.1,Fatigue,16924882,
0,22.1,Fractured coccyx,16925001,
1,22.1,Diarrhoea,16925001,
0,22.1,Thrombosis,16925229,
0,22.1,Arthralgia,16925402,
0,22.1,Dehydration,16925485,
1,22.1,Diarrhoea,16925485,
0,22.1,Platelet count decreased,16925527,
1,22.1,Red blood cell count decreased,16925527,
0,22.1,Blister,16925529,
0,22.1,Infection,16925531,
0,22.1,Peripheral swelling,16925533,
0,22.1,Pneumonia,16925759,
0,22.1,Respiratory disorder,16925951,
0,22.1,Pneumonia,16929124,
0,22.1,Renal disorder,16929407,
0,22.1,Nausea,16929454,
1,22.1,Dizziness,16929454,
2,22.1,Chills,16929454,
3,22.1,Decreased appetite,16929454,
4,22.1,Diarrhoea,16929454,
5,22.1,Pyrexia,16929454,
0,22.1,Catheterisation cardiac,16929462,
0,22.1,Fall,16929734,
1,22.1,Femur fracture,16929734,
2,22.1,Therapy cessation,16929734,
0,22.1,Back pain,16929780,
1,22.1,Pain in extremity,16929780,
2,22.1,Fatigue,16929780,
3,22.1,Decreased appetite,16929780,
4,22.1,Nausea,16929780,
0,22.1,Diarrhoea,16929862,
1,22.1,Feeling abnormal,16929862,
2,22.1,Depression,16929862,
3,22.1,Abdominal discomfort,16929862,
4,22.1,Nausea,16929862,
5,22.1,Vomiting,16929862,
0,22.1,Diarrhoea,16929938,
0,22.1,Insomnia,16930189,
1,22.1,Cystitis,16930189,
0,22.1,Hypertension,16930194,
1,22.1,Muscle spasms,16930194,
2,22.1,Constipation,16930194,
3,22.1,Disorientation,16930194,
4,22.1,Vision blurred,16930194,
0,22.1,Dysphonia,16931050,
1,22.1,Product substitution issue,16931050,
2,22.1,Urticaria,16931050,
3,22.1,Dyspnoea,16931050,
0,22.1,Cardiac failure,16931308,
0,22.1,Hot flush,16933670,
0,22.1,Vertigo,16933675,
1,22.1,Post procedural complication,16933675,
2,22.1,Headache,16933675,
0,22.1,Diarrhoea,16934328,
1,22.1,Immune-mediated enterocolitis,16934328,
2,22.1,Decreased appetite,16934328,
3,22.1,Fatigue,16934328,
4,22.1,Asthenia,16934328,
5,22.1,Therapy cessation,16934328,
0,22.1,Death,16934867,
0,22.1,Ocular icterus,16934925,
1,22.1,Asthenia,16934925,
2,22.1,Fatigue,16934925,
0,22.1,Drug ineffective,16934975,
0,22.1,Memory impairment,16935306,
1,22.1,Inappropriate schedule of product administration,16935306,
0,22.1,Disease progression,16935549,
0,22.1,Dehydration,16935755,
1,22.1,Diarrhoea,16935755,
2,22.1,Urinary tract infection,16935755,
0,22.1,Cerebrovascular accident,16935845,
1,22.1,Hypertension,16935845,
2,22.1,Fall,16935845,
0,22.1,Death,16935959,
0,22.1,Alopecia,16936469,
0,22.1,Hypertension,16938425,
1,22.1,Fall,16938425,
2,22.1,Headache,16938425,
3,22.1,Cerebrovascular accident,16938425,
4,22.1,Hypoaesthesia,16938425,
0,22.1,Drug ineffective,16938539,
0,22.1,Haematochezia,16938611,
0,22.1,Product supply issue,16938686,
1,22.1,Alopecia,16938686,
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,16938908,
1,22.1,Mucosal inflammation,16938908,
0,22.1,Disease progression,16938923,
0,22.1,Death,16940586,
0,22.1,Skin ulcer,16940869,
0,22.1,Product dose omission,16940997,
1,22.1,Product storage error,16940997,
0,22.1,Therapy cessation,16941145,
1,22.1,Colon operation,16941145,
0,22.1,Urticaria,16941235,
1,22.1,Swelling,16941235,
2,22.1,Rash,16941235,
0,22.1,Urticaria,16941238,
1,22.1,Rash,16941238,
2,22.1,Swelling,16941238,
0,22.1,Migraine,16941286,
1,22.1,Nausea,16941286,
2,22.1,Vomiting,16941286,
0,22.1,Headache,16941313,
1,22.1,Rhinorrhoea,16941313,
0,22.1,Drug ineffective,16941427,
0,22.1,Abdominal pain,16941557,
0,22.1,Surgery,16941595,
0,22.1,Drug ineffective,16941613,
0,22.1,Peripheral swelling,16941650,
0,22.1,Rash,16941678,
1,22.1,Aphonia,16941678,
0,22.1,Death,16941704,
0,22.1,Fatigue,16941756,
0,22.1,Cardiac failure congestive,16941784,
0,22.1,Death,16941823,
0,22.1,Drug ineffective,16945321,
0,22.1,White blood cell count decreased,16945462,
0,22.1,Disease progression,16945527,
0,22.1,Fatigue,16945593,
1,22.1,Asthenia,16945593,
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,16945602,
0,22.1,Dyspnoea,16945676,
0,22.1,Syncope,16945791,
1,22.1,Lymphoedema,16945791,
2,22.1,Cardiac murmur,16945791,
3,22.1,Fatigue,16945791,
0,22.1,Drug ineffective,16946002,
0,22.1,Blood test abnormal,16946164,
0,22.1,Death,16946486,
0,22.1,Nausea,16946573,
1,22.1,Fatigue,16946573,
0,22.1,Ascites,16946673,
0,22.1,Abdominal pain upper,16946803,
1,22.1,Alopecia,16946803,
2,22.1,Nausea,16946803,
0,22.1,Neutropenia,16946885,
0,22.1,Amnesia,16946887,
0,22.1,Metastases to spine,16762669,6
1,22.1,Hypertension,16762669,6
2,22.1,Cerebral haemorrhage,16762669,6
3,22.1,Abdominal discomfort,16762669,6
0,22.1,Nausea,16762723,3
1,22.1,Hyperglycaemia,16762723,1
2,22.1,Tumour marker abnormal,16762723,6
3,22.1,Fatigue,16762723,3
4,22.1,Dizziness,16762723,6
5,22.1,Diarrhoea,16762723,3
0,22.0,Pulmonary oedema,16762779,6
1,22.0,Hypoaesthesia,16762779,6
0,22.1,Wrong technique in product usage process,16762788,6
1,22.1,Device use error,16762788,6
0,22.1,Hospitalisation,16762805,6
0,22.0,Platelet count decreased,16762819,1
0,22.0,Product use in unapproved indication,16762838,6
1,22.0,Rash pruritic,16762838,2
2,22.0,Death,16762838,5
0,22.0,Hypertension,16762839,2
1,22.0,Product use issue,16762839,6
0,22.1,Cholangitis sclerosing,16762841,2
0,22.1,Malignant neoplasm progression,16762844,6
1,22.1,Renal impairment,16762844,2
2,22.1,Rash,16762844,2
0,22.0,Osteonecrosis of jaw,16762877,6
1,22.0,Acute myeloid leukaemia,16762877,2
2,22.0,Second primary malignancy,16762877,2
0,22.0,Malignant neoplasm progression,16762880,5
1,22.0,Interstitial lung disease,16762880,2
0,22.1,Stevens-Johnson syndrome,16762909,3
0,22.0,Multicentric reticulohistiocytosis,16762910,6
1,22.0,Breast cancer recurrent,16762910,6
0,22.1,Device malfunction,16762917,6
0,22.0,Gingival bleeding,16762931,6
1,22.0,Platelet count decreased,16762931,2
0,22.0,Confusional state,16762937,6
1,22.0,Encephalitis,16762937,6
2,22.0,Encephalopathy,16762937,6
0,22.0,Unevaluable event,16762939,6
0,22.0,Osteonecrosis,16762973,3
0,22.0,Metastases to liver,16762977,6
1,22.0,Pathological fracture,16762977,6
2,22.0,Osteonecrosis of jaw,16762977,6
3,22.0,Paraplegia,16762977,6
4,22.0,Metastases to bone,16762977,6
5,22.0,Hypertension,16762977,6
6,22.0,Metastases to pleura,16762977,6
0,22.0,Asthenia,16763019,6
1,22.0,Adrenal disorder,16763019,6
0,22.0,Pemphigoid,16763025,1
0,22.0,Vomiting,16763027,6
1,22.0,Nausea,16763027,6
2,22.0,Lipase increased,16763027,6
3,22.0,Obstruction gastric,16763027,6
0,22.0,Bradycardia,16763038,1
1,22.0,Electrocardiogram QT prolonged,16763038,1
2,22.0,Headache,16763038,1
3,22.0,Nausea,16763038,1
4,22.0,Vomiting,16763038,1
0,22.0,Palpitations,16763041,2
1,22.0,Cyanosis,16763041,2
2,22.0,Chest discomfort,16763041,2
0,22.0,Interstitial lung disease,16763044,6
1,22.0,Polymyositis,16763044,6
2,22.0,Cholangitis,16763044,6
3,22.0,Type 1 diabetes mellitus,16763044,6
4,22.0,Renal disorder,16763044,6
5,22.0,Hepatitis,16763044,6
0,22.1,Intentional product use issue,16763082,6
1,22.1,Off label use,16763082,6
2,22.1,Oropharyngeal pain,16763082,1
3,22.1,Febrile neutropenia,16763082,2
0,22.1,Hypotension,16763119,6
1,22.1,Asthenia,16763119,6
2,22.1,Fatigue,16763119,6
0,22.0,Urethritis noninfective,16763137,6
0,22.0,Nausea,16763153,6
1,22.0,Drug ineffective,16763153,6
2,22.0,Discomfort,16763153,6
3,22.0,General physical health deterioration,16763153,6
4,22.0,Diarrhoea,16763153,6
5,22.0,Bile duct obstruction,16763153,6
0,22.0,Hepatic cancer,16763154,5
0,22.0,Blood creatinine increased,16763240,2
1,22.0,Hyperglycaemia,16763240,2
0,22.0,Urticaria,16763256,6
1,22.0,Stomatitis,16763256,2
2,22.0,Asthenia,16763256,6
3,22.0,Blood alkaline phosphatase increased,16763256,6
4,22.0,Blood sodium decreased,16763256,6
5,22.0,Blood urea increased,16763256,6
6,22.0,Blood glucose increased,16763256,6
7,22.0,Blood calcium decreased,16763256,6
8,22.0,Drug intolerance,16763256,6
9,22.0,Rash,16763256,1
10,22.0,Diarrhoea,16763256,6
11,22.0,Blister,16763256,6
12,22.0,Skin exfoliation,16763256,6
13,22.0,Red cell distribution width increased,16763256,6
14,22.0,Renal function test abnormal,16763256,6
15,22.0,Pain of skin,16763256,6
16,22.0,Mean cell haemoglobin increased,16763256,6
17,22.0,Blood chloride decreased,16763256,6
18,22.0,Mass,16763256,6
19,22.0,Alanine aminotransferase decreased,16763256,6
20,22.0,Blood creatinine increased,16763256,6
21,22.0,Type I hypersensitivity,16763256,6
22,22.0,Throat tightness,16763256,6
23,22.0,Gastric disorder,16763256,6
24,22.0,Dyspnoea,16763256,1
25,22.0,Blood potassium decreased,16763256,6
26,22.0,Mucosal inflammation,16763256,1
0,22.0,Lung neoplasm malignant,16763301,3
0,22.0,Metastases to bone,16763306,6
1,22.0,Hot flush,16763306,3
2,22.0,Urine odour abnormal,16763306,3
3,22.0,Asthenia,16763306,3
0,22.0,Bone marrow failure,16763329,2
0,22.0,Cholecystitis infective,16763338,1
1,22.0,Platelet count decreased,16763338,1
0,22.0,Influenza like illness,16763348,6
0,22.1,Neutropenia,16763432,6
0,22.0,Anaemia,16763438,3
1,22.0,Pyrexia,16763438,3
0,22.1,Diverticulum,16763466,2
0,22.0,Death,16763476,5
0,22.0,Malaise,16763477,3
1,22.0,Mobility decreased,16763477,3
0,22.0,Rash,16763507,6
0,22.0,Second primary malignancy,16763516,6
1,22.0,Ovarian cancer,16763516,6
0,22.0,Death,16763518,5
0,22.0,Gait inability,16763524,6
1,22.0,Arthralgia,16763524,6
0,22.0,Death,16763527,5
0,22.1,Decreased appetite,16763528,6
1,22.1,White blood cell count decreased,16763528,6
2,22.1,Tumour marker increased,16763528,6
3,22.1,Onychoclasis,16763528,6
4,22.1,Fatigue,16763528,6
5,22.1,Neoplasm progression,16763528,6
6,22.1,Full blood count decreased,16763528,6
7,22.1,Asthenia,16763528,6
8,22.1,Constipation,16763528,6
9,22.1,Skin exfoliation,16763528,6
10,22.1,Flushing,16763528,6
11,22.1,Hypoaesthesia,16763528,6
0,22.0,Dysstasia,16763533,6
1,22.0,Arthropathy,16763533,6
2,22.0,Pain,16763533,6
3,22.0,Musculoskeletal disorder,16763533,6
0,22.0,Therapy partial responder,16763546,6
0,22.0,Neuropathy peripheral,16763566,6
0,22.0,Body temperature decreased,16763576,6
0,22.0,Blood calcium decreased,16763601,6
1,22.0,Death,16763601,5
0,22.0,Death,16763609,5
1,22.0,Peripheral swelling,16763609,6
2,22.0,Lymphatic disorder,16763609,6
3,22.0,Oedema,16763609,6
4,22.0,Eczema,16763609,6
5,22.0,Somnolence,16763609,6
6,22.0,Malaise,16763609,6
7,22.0,Movement disorder,16763609,6
0,22.0,Staphylococcal sepsis,16763618,2
1,22.0,Skin disorder,16763618,6
0,22.0,Fatigue,16763656,6
1,22.0,Anaemia,16763656,6
2,22.0,Leukopenia,16763656,6
3,22.0,Neutrophil count decreased,16763656,6
4,22.0,Off label use,16763656,6
5,22.0,Carbohydrate antigen 15-3 increased,16763656,6
6,22.0,Carcinoembryonic antigen increased,16763656,6
7,22.0,Product use in unapproved indication,16763656,6
0,22.0,Seizure,16763659,6
1,22.0,Enuresis,16763659,6
2,22.0,Drug eruption,16763659,6
3,22.0,Infection,16763659,6
0,22.0,Infection,16763662,6
1,22.0,White blood cell disorder,16763662,6
2,22.0,Hepatic function abnormal,16763662,6
3,22.0,Death,16763662,5
4,22.0,Neutropenia,16763662,6
0,22.0,Death,16763721,5
1,22.0,Decreased appetite,16763721,1
2,22.0,Fatigue,16763721,1
0,22.1,Leukopenia,16763734,6
1,22.1,Taste disorder,16763734,6
2,22.1,Fatigue,16763734,6
3,22.1,Decreased appetite,16763734,6
4,22.1,Hot flush,16763734,6
5,22.1,Nasopharyngitis,16763734,6
6,22.1,Urinary tract infection,16763734,6
7,22.1,Neuropathy peripheral,16763734,3
8,22.1,Arthralgia,16763734,6
9,22.1,Nausea,16763734,6
0,22.0,Nausea,16763746,3
1,22.0,Diarrhoea,16763746,3
2,22.0,Skin irritation,16763746,6
3,22.0,Onychalgia,16763746,3
4,22.0,Epistaxis,16763746,6
5,22.0,Electrolyte imbalance,16763746,1
6,22.0,Hair texture abnormal,16763746,6
7,22.0,Oral herpes,16763746,3
8,22.0,Eye pruritus,16763746,6
9,22.0,Dysphonia,16763746,3
10,22.0,Pulmonary thrombosis,16763746,6
11,22.0,Rhinorrhoea,16763746,6
12,22.0,Oral discomfort,16763746,6
13,22.0,Haemoglobin decreased,16763746,6
14,22.0,Constipation,16763746,6
15,22.0,Nail bed infection,16763746,3
16,22.0,Diarrhoea,16763746,6
17,22.0,Skin ulcer,16763746,6
18,22.0,Malignant neoplasm progression,16763746,6
19,22.0,Migraine,16763746,3
20,22.0,Nail discolouration,16763746,3
21,22.0,Vision blurred,16763746,6
22,22.0,Brain operation,16763746,6
23,22.0,Treatment failure,16763746,6
24,22.0,Alopecia,16763746,3
25,22.0,Stomatitis,16763746,3
26,22.0,Eye infection,16763746,6
27,22.0,General physical health deterioration,16763746,3
28,22.0,Eye irritation,16763746,6
29,22.0,Alopecia,16763746,6
30,22.0,Lacrimation increased,16763746,6
31,22.0,Dermatitis acneiform,16763746,3
32,22.0,Discomfort,16763746,6
0,22.0,Febrile bone marrow aplasia,16763776,2
1,22.0,Drug clearance decreased,16763776,6
2,22.0,Drug clearance increased,16763776,6
3,22.0,Drug interaction,16763776,6
0,22.1,Lip swelling,16763808,6
1,22.1,Injection site pruritus,16763808,2
2,22.1,Gait inability,16763808,6
3,22.1,Hepatic cancer recurrent,16763808,6
4,22.1,General physical health deterioration,16763808,6
5,22.1,Platelet count decreased,16763808,6
6,22.1,Dysuria,16763808,6
7,22.1,Retinal disorder,16763808,6
8,22.1,Transaminases increased,16763808,6
9,22.1,Mucosal inflammation,16763808,3
10,22.1,Abdominal pain,16763808,6
11,22.1,Headache,16763808,6
12,22.1,Abdominal distension,16763808,6
13,22.1,Pyrexia,16763808,6
14,22.1,Pharyngeal ulceration,16763808,6
15,22.1,Eye discharge,16763808,6
16,22.1,Incorrect route of product administration,16763808,6
17,22.1,Insomnia,16763808,3
18,22.1,Asthenia,16763808,6
19,22.1,Proctalgia,16763808,6
20,22.1,Inflammation,16763808,3
21,22.1,Limb discomfort,16763808,6
22,22.1,Dry skin,16763808,3
23,22.1,Plicated tongue,16763808,6
24,22.1,Abdominal pain upper,16763808,6
25,22.1,Oral mucosal blistering,16763808,6
26,22.1,Lacrimation increased,16763808,6
27,22.1,Oropharyngeal pain,16763808,6
28,22.1,Pain,16763808,3
29,22.1,Pruritus,16763808,3
30,22.1,Swelling,16763808,6
31,22.1,Mass,16763808,6
32,22.1,Injection site hypersensitivity,16763808,2
33,22.1,Thirst,16763808,6
34,22.1,Anal inflammation,16763808,3
35,22.1,Food aversion,16763808,6
36,22.1,Weight decreased,16763808,6
37,22.1,Dysphonia,16763808,6
38,22.1,Rash,16763808,6
39,22.1,Tremor,16763808,6
40,22.1,Pain in extremity,16763808,6
41,22.1,Visual impairment,16763808,6
42,22.1,Hepatic mass,16763808,3
43,22.1,Product use in unapproved indication,16763808,6
44,22.1,Glaucoma,16763808,6
45,22.1,Dry eye,16763808,6
46,22.1,Skin hypertrophy,16763808,6
47,22.1,Hyperhidrosis,16763808,6
48,22.1,Skin laceration,16763808,6
49,22.1,Nail disorder,16763808,6
50,22.1,Flatulence,16763808,6
51,22.1,Blood chromogranin A increased,16763808,6
52,22.1,Malaise,16763808,6
53,22.1,Lip dry,16763808,6
54,22.1,Odynophagia,16763808,6
55,22.1,Abscess limb,16763808,6
56,22.1,Injection site bruising,16763808,2
57,22.1,Cataract,16763808,6
58,22.1,Anorectal swelling,16763808,6
59,22.1,Arthritis,16763808,6
60,22.1,Tachycardia,16763808,3
61,22.1,Constipation,16763808,6
62,22.1,Burning sensation,16763808,3
63,22.1,Skin ulcer,16763808,6
64,22.1,Tongue ulceration,16763808,6
65,22.1,Oral mucosal exfoliation,16763808,6
66,22.1,Ocular hyperaemia,16763808,6
67,22.1,Decreased appetite,16763808,6
68,22.1,Therapeutic product effect incomplete,16763808,6
69,22.1,Bone pain,16763808,6
70,22.1,Diarrhoea,16763808,6
71,22.1,Tongue blistering,16763808,6
72,22.1,Nausea,16763808,6
73,22.1,Incorrect dose administered,16763808,6
74,22.1,Oral bacterial infection,16763808,6
75,22.1,Injection site warmth,16763808,2
76,22.1,Injection site pain,16763808,2
77,22.1,Muscular weakness,16763808,6
78,22.1,Eye irritation,16763808,6
79,22.1,Contusion,16763808,6
80,22.1,Skin exfoliation,16763808,6
81,22.1,Mouth injury,16763808,6
82,22.1,Hypersensitivity,16763808,6
83,22.1,Vomiting,16763808,6
84,22.1,Haemoglobin decreased,16763808,6
85,22.1,Blister,16763808,6
86,22.1,Tongue dry,16763808,6
87,22.1,Food intolerance,16763808,6
88,22.1,Breast mass,16763808,6
89,22.1,Oral disorder,16763808,6
90,22.1,Stomatitis,16763808,3
91,22.1,Haemorrhoids,16763808,3
92,22.1,Dysbiosis,16763808,6
93,22.1,Proctitis,16763808,6
94,22.1,Skin fissures,16763808,6
95,22.1,Balance disorder,16763808,6
96,22.1,Oral pruritus,16763808,6
97,22.1,Dizziness,16763808,6
98,22.1,Gastritis,16763808,6
0,22.0,Death,16763811,5
0,22.0,Rash,16763852,2
0,22.0,No adverse event,16763885,6
0,22.0,Death,16763894,5
0,22.0,Death,16763901,5
0,22.0,Oesophagobronchial fistula,16763921,1
1,22.0,Pneumonia,16763921,1
0,22.1,Insomnia,16763973,3
1,22.1,Electrocardiogram ST-T change,16763973,3
2,22.1,Diarrhoea,16763973,3
3,22.1,Vomiting,16763973,3
4,22.1,Dyspnoea,16763973,3
5,22.1,Sinus tachycardia,16763973,3
6,22.1,Oedema peripheral,16763973,3
7,22.1,Abdominal distension,16763973,3
8,22.1,Pulmonary embolism,16763973,3
9,22.1,Nausea,16763973,3
0,22.0,Death,16763976,5
0,22.0,Death,16763978,5
0,22.0,Death,16764004,5
0,22.0,Intentional product misuse,16764031,6
1,22.0,Malignant neoplasm progression,16764031,3
0,22.1,Anaemia,16764033,2
1,22.1,C-reactive protein increased,16764033,6
2,22.1,Blood urea increased,16764033,6
3,22.1,Gamma-glutamyltransferase increased,16764033,6
4,22.1,Liver function test increased,16764033,6
5,22.1,Thrombocytopenia,16764033,3
6,22.1,Blood alkaline phosphatase increased,16764033,6
7,22.1,Neutropenia,16764033,3
8,22.1,Blood lactate dehydrogenase increased,16764033,6
9,22.1,Aspartate aminotransferase increased,16764033,6
0,22.0,Malignant neoplasm progression,16764093,6
1,22.0,Metastases to liver,16764093,6
0,22.1,Haematotoxicity,16764127,6
0,22.0,Photosensitivity reaction,16764147,6
1,22.0,Sinus disorder,16764147,6
2,22.0,Neuropathy peripheral,16764147,6
3,22.0,Product use in unapproved indication,16764147,6
0,22.1,Drug ineffective,16764188,6
1,22.1,Hospitalisation,16764188,6
2,22.1,Malaise,16764188,3
3,22.1,Blood count abnormal,16764188,6
4,22.1,Adverse event,16764188,6
5,22.1,Product dose omission,16764188,6
6,22.1,Nausea,16764188,6
7,22.1,Constipation,16764188,6
0,22.1,Nephrolithiasis,16764191,6
1,22.1,Hospitalisation,16764191,6
0,22.0,Feeling abnormal,16764261,1
1,22.0,Flushing,16764261,1
0,22.0,Nausea,16764271,5
1,22.0,Oral candidiasis,16764271,5
2,22.0,Malaise,16764271,5
3,22.0,Malaise,16764271,5
4,22.0,Tachypnoea,16764271,5
5,22.0,Stomatitis,16764271,5
6,22.0,Vomiting,16764271,5
7,22.0,Productive cough,16764271,5
8,22.0,Hypoxia,16764271,5
9,22.0,Hypophagia,16764271,5
10,22.0,Neutropenic sepsis,16764271,5
11,22.0,Hypotension,16764271,5
12,22.0,Arrhythmia,16764271,5
13,22.0,Tachycardia,16764271,5
14,22.0,Oropharyngeal pain,16764271,5
15,22.0,Body temperature increased,16764271,5
0,22.0,Abdominal pain,16764295,6
1,22.0,Ascites,16764295,6
2,22.0,Neoplasm progression,16764295,6
3,22.0,Aphasia,16764295,6
4,22.0,Movement disorder,16764295,6
5,22.0,Abdominal distension,16764295,6
6,22.0,Eating disorder,16764295,6
0,22.0,Neoplasm progression,16764297,3
1,22.0,Haematuria,16764297,6
0,22.0,Acne,16764366,6
1,22.0,Diarrhoea,16764366,6
2,22.0,Rash,16764366,6
0,22.0,Renal cell carcinoma,16764368,3
1,22.0,Second primary malignancy,16764368,3
0,22.0,Neutropenia,16764382,6
1,22.0,Pneumonia,16764382,6
2,22.0,Dyspnoea,16764382,6
0,22.0,Acute myocardial infarction,16764417,1
0,22.1,Adverse event,16764459,6
1,22.1,Cardiac disorder,16764459,5
0,22.0,Vomiting,16764476,1
0,22.0,Adenocarcinoma,16764477,5
1,22.0,Diverticular perforation,16764477,6
0,22.1,Hyperthyroidism,16764494,2
1,22.1,Loss of consciousness,16764494,1
0,22.1,Mitral valve incompetence,16764506,3
0,22.1,Pemphigoid,16764512,2
1,22.1,Colitis,16764512,2
2,22.1,Diarrhoea,16764512,6
3,22.1,Febrile neutropenia,16764512,2
4,22.1,Acute kidney injury,16764512,1
5,22.1,Interstitial lung disease,16764512,1
6,22.1,Adrenocorticotropic hormone deficiency,16764512,2
0,22.0,Death,16764591,5
0,22.0,Death,16764610,5
0,22.0,Death,16764611,5
0,22.0,Rash,16764630,6
0,22.0,Interstitial lung disease,16764637,3
0,22.0,Renal failure,16764764,6
1,22.0,Bone marrow failure,16764764,6
0,22.0,Vision blurred,16764843,2
0,22.0,Hyperglycaemia,16764874,2
1,22.0,Vision blurred,16764874,6
0,22.0,Jaundice cholestatic,16764888,6
0,22.0,Oral disorder,16764903,1
0,22.0,Drug reaction with eosinophilia and systemic symptoms,16764985,2
0,22.0,Neoplasm malignant,16764991,5
0,22.1,Central nervous system vasculitis,16765003,3
0,22.1,Respiratory distress,16765073,6
1,22.1,Chest discomfort,16765073,6
2,22.1,Dizziness,16765073,6
0,22.0,White blood cell count decreased,16765108,6
1,22.0,Uterine cancer,16765108,3
2,22.0,Palpitations,16765108,1
3,22.0,Arthralgia,16765108,6
4,22.0,"Sleep disorder due to general medical condition, insomnia type",16765108,6
0,22.0,Acute myeloid leukaemia,16765138,5
1,22.0,Death,16765138,5
0,22.0,Bone marrow failure,16765171,1
0,22.0,Death,16765209,5
0,22.0,Death,16765220,5
0,22.0,Diarrhoea,16765222,6
1,22.0,Product use in unapproved indication,16765222,6
0,22.0,Hepatic function abnormal,16765226,2
0,22.0,Abdominal pain lower,16765245,6
1,22.0,Appendicitis perforated,16765245,1
2,22.0,Appendiceal abscess,16765245,1
0,22.0,Neutrophil count decreased,16765248,6
1,22.0,Metastases to bone marrow,16765248,6
0,22.0,Rash,16765334,2
0,22.0,Taste disorder,16765385,6
1,22.0,Nausea,16765385,6
2,22.0,Decreased appetite,16765385,6
0,22.0,Leukopenia,16765416,6
1,22.0,Malignant neoplasm progression,16765416,6
2,22.0,Anaemia,16765416,6
3,22.0,Carcinoembryonic antigen increased,16765416,6
4,22.0,Neutrophil count decreased,16765416,6
5,22.0,Carbohydrate antigen 15-3 increased,16765416,6
0,22.0,Lip swelling,16765475,6
1,22.0,Mouth ulceration,16765475,6
2,22.0,Rash generalised,16765475,6
0,22.0,Septic shock,16765561,1
1,22.0,Leukopenia,16765561,1
2,22.0,Thrombocytopenia,16765561,1
3,22.0,Anaemia,16765561,3
0,22.0,Asthenia,16765567,6
1,22.0,Pain,16765567,6
2,22.0,Fatigue,16765567,6
3,22.0,Abnormal loss of weight,16765567,6
0,22.0,Optic ischaemic neuropathy,16765574,3
1,22.0,Optic disc drusen,16765574,3
0,22.0,Cardiomyopathy,16765689,2
0,22.1,Platelet count decreased,16765700,3
1,22.1,Neutrophil count decreased,16765700,3
2,22.1,Pneumonitis,16765700,1
0,22.1,Herpes ophthalmic,16765702,2
0,22.0,Progressive multifocal leukoencephalopathy,16765730,3
0,22.0,Alopecia,16765752,6
1,22.0,Rash pustular,16765752,2
2,22.0,Skin erosion,16765752,2
0,22.0,Appendicitis perforated,16765782,1
1,22.0,Appendiceal abscess,16765782,1
2,22.0,Abdominal pain lower,16765782,6
0,22.0,Rash,16765783,6
0,22.0,Implant site pain,16765789,3
1,22.0,Osteonecrosis of jaw,16765789,3
0,22.0,Nasopharyngitis,16765792,6
1,22.0,Immunodeficiency,16765792,5
2,22.0,Dyspnoea,16765792,6
0,22.0,Hot flush,16765811,6
1,22.0,Hyperhidrosis,16765811,6
2,22.0,Abdominal pain upper,16765811,6
3,22.0,Gait disturbance,16765811,6
4,22.0,Polyarthritis,16765811,3
5,22.0,Memory impairment,16765811,6
0,22.0,Metastases to bone,16765823,1
1,22.0,Metastases to bone,16765823,6
2,22.0,Prostatic specific antigen increased,16765823,2
0,22.0,Malignant neoplasm progression,16765826,6
1,22.0,Adrenal insufficiency,16765826,1
0,22.0,Febrile neutropenia,16765835,1
1,22.0,Platelet count decreased,16765835,1
0,22.0,Pneumoperitoneum,16765856,2
1,22.0,Intestinal perforation,16765856,6
2,22.0,Diarrhoea,16765856,1
3,22.0,Pneumatosis intestinalis,16765856,2
4,22.0,Acute kidney injury,16765856,2
5,22.0,Gastrointestinal inflammation,16765856,2
0,22.0,Dental implantation,16765871,6
0,22.0,Tuberculosis,16765901,6
0,22.1,Death,16765908,5
1,22.1,Cerebrovascular accident,16765908,3
2,22.1,Dysphagia,16765908,3
0,22.0,Ischaemic stroke,16765939,2
0,22.1,Death,16765974,5
0,22.1,Neuroendocrine carcinoma,16765975,6
0,22.0,Cardiac disorder,16765985,5
0,22.0,Shock haemorrhagic,16766016,6
1,22.0,Peptic ulcer,16766016,6
0,22.0,Cushingoid,16766020,6
1,22.0,Osteonecrosis,16766020,6
2,22.0,Fatigue,16766020,6
0,22.1,Pneumonia,16766056,1
0,22.0,General physical health deterioration,16766067,6
1,22.0,Death,16766067,5
2,22.0,Swelling,16766067,6
3,22.0,Bone pain,16766067,6
4,22.0,Diplegia,16766067,6
5,22.0,Pelvic pain,16766067,6
6,22.0,Decreased appetite,16766067,6
0,22.1,Surgery,16766072,6
1,22.1,Infection,16766072,6
0,22.0,Bone marrow failure,16766104,2
1,22.0,Septic shock,16766104,2
2,22.0,Acute kidney injury,16766104,2
0,22.0,General physical health deterioration,16766108,6
0,22.0,Brain oedema,16766145,6
1,22.0,Metastases to central nervous system,16766145,6
2,22.0,Malignant neoplasm progression,16766145,6
3,22.0,Altered state of consciousness,16766145,6
4,22.0,Metastases to spine,16766145,6
0,22.0,Myalgia,16766158,6
1,22.0,Vomiting,16766158,6
2,22.0,Haemoglobin decreased,16766158,6
3,22.0,Musculoskeletal pain,16766158,6
4,22.0,Rash pruritic,16766158,6
5,22.0,Palpitations,16766158,6
6,22.0,Back pain,16766158,6
7,22.0,Nausea,16766158,6
8,22.0,Flank pain,16766158,6
9,22.0,Renal impairment,16766158,6
0,22.0,Trousseau^s syndrome,16766184,6
0,22.0,Tachycardia,16766189,6
1,22.0,Interstitial lung disease,16766189,6
0,22.0,Gastric ulcer,16766296,1
0,22.1,Thrombophlebitis superficial,16766306,1
0,22.0,Fall,16766307,6
1,22.0,Adverse event,16766307,6
2,22.0,Asthenia,16766307,6
0,22.0,Asthenia,16766316,6
1,22.0,Diarrhoea,16766316,6
0,22.1,Urinary tract infection,16766335,1
1,22.1,Enterobacter infection,16766335,6
2,22.1,Pyrexia,16766335,6
3,22.1,Kidney infection,16766335,1
4,22.1,Liver abscess,16766335,1
0,22.0,Hypersensitivity vasculitis,16766357,2
1,22.0,Pseudocellulitis,16766357,2
0,22.0,Blood cholesterol increased,16766361,6
1,22.0,Glaucoma,16766361,6
2,22.0,Paraesthesia,16766361,1
3,22.0,Blood pressure increased,16766361,6
4,22.0,Cataract,16766361,1
5,22.0,Depression,16766361,1
6,22.0,Insomnia,16766361,1
7,22.0,Hot flush,16766361,1
0,22.0,Rash,16766390,3
0,22.0,Pancreatitis acute,16766410,1
1,22.0,Pancreatitis acute,16766410,1
0,22.0,Off label use,16766446,6
1,22.0,Death,16766446,5
0,22.1,Pneumonia,16766447,3
1,22.1,Blister,16766447,6
2,22.1,Pyrexia,16766447,2
3,22.1,White blood cell count increased,16766447,2
4,22.1,Rash,16766447,3
0,22.0,Metastases to central nervous system,16766457,6
1,22.0,Oestradiol abnormal,16766457,6
2,22.0,Drug ineffective,16766457,6
3,22.0,Endometriosis,16766457,6
0,22.0,Systemic lupus erythematosus,16766492,1
0,22.1,Intestinal resection,16766501,6
1,22.1,Nausea,16766501,6
2,22.1,Carbohydrate antigen 125 increased,16766501,6
3,22.1,White blood cell count decreased,16766501,6
4,22.1,Haemoglobin decreased,16766501,6
5,22.1,Red blood cell count decreased,16766501,6
6,22.1,Platelet count decreased,16766501,3
0,22.0,Laboratory test abnormal,16766557,6
0,22.1,Urinary tract infection,16766573,6
1,22.1,Gastrooesophageal reflux disease,16766573,6
2,22.1,Back pain,16766573,6
3,22.1,Hypertension,16766573,6
0,22.1,Anxiety,16766574,6
1,22.1,Procedural pain,16766574,6
2,22.1,Nausea,16766574,6
0,22.0,Malignant neoplasm progression,16766608,6
1,22.0,Death,16766608,5
0,22.1,Stomatitis,16766625,6
1,22.1,Necrosis,16766625,6
2,22.1,Groin pain,16766625,3
3,22.1,Arthralgia,16766625,3
4,22.1,Nausea,16766625,3
5,22.1,Oral mucosal eruption,16766625,6
6,22.1,Neoplasm progression,16766625,3
7,22.1,Arthritis,16766625,6
0,22.0,Ileus,16766689,1
1,22.0,Pain,16766689,4
0,22.0,Dysphagia,16766725,6
0,22.1,Malignant neoplasm progression,16766760,6
1,22.1,Breast cancer,16766760,6
2,22.1,Metastases to bone,16766760,6
3,22.1,Metastases to peritoneum,16766760,6
4,22.1,Metastases to skin,16766760,6
5,22.1,Breast cancer metastatic,16766760,6
6,22.1,Metastases to liver,16766760,6
0,22.0,Neoplasm progression,16766772,6
0,22.1,Loss of personal independence in daily activities,16766777,6
1,22.1,Fall,16766777,3
2,22.1,Balance disorder,16766777,3
3,22.1,Asthenia,16766777,3
4,22.1,Death,16766777,5
5,22.1,Fatigue,16766777,1
0,22.0,Pyrexia,16766794,1
1,22.0,Headache,16766794,3
0,22.0,Depression,16766836,6
0,22.1,Decreased appetite,16766848,
1,22.1,Fatigue,16766848,
2,22.1,Dysphonia,16766848,
3,22.1,Vomiting,16766848,
4,22.1,Dyspnoea,16766848,
5,22.1,Mental status changes,16766848,
6,22.1,Asthenia,16766848,
0,22.1,Gait disturbance,16766851,6
0,22.0,Rectal cancer recurrent,16766913,6
1,22.0,Rectal cancer stage II,16766913,5
2,22.0,Product use in unapproved indication,16766913,6
3,22.0,Malignant neoplasm progression,16766913,5
0,22.1,Influenza,16767006,6
1,22.1,Vomiting,16767006,3
2,22.1,Sinus disorder,16767006,2
3,22.1,Seasonal allergy,16767006,6
0,22.0,Osteonecrosis of jaw,16767048,1
0,22.0,Interstitial lung disease,16767079,2
0,22.0,Postrenal failure,16767109,6
0,22.1,Neoplasm progression,16767136,6
0,22.1,Product use in unapproved indication,16767143,6
1,22.1,Fatigue,16767143,3
2,22.1,Neoplasm progression,16767143,6
3,22.1,Off label use,16767143,6
0,22.1,Blood pressure decreased,16767155,6
1,22.1,Fatigue,16767155,6
2,22.1,Arthralgia,16767155,6
3,22.1,Burning sensation,16767155,6
4,22.1,Pain of skin,16767155,6
5,22.1,Blister,16767155,6
6,22.1,Head injury,16767155,6
7,22.1,Asthenia,16767155,6
8,22.1,Loss of consciousness,16767155,6
9,22.1,Malaise,16767155,6
10,22.1,Fall,16767155,6
11,22.1,Vomiting,16767155,6
12,22.1,Back pain,16767155,6
13,22.1,Dizziness,16767155,6
14,22.1,Nausea,16767155,6
15,22.1,Stomatitis,16767155,6
0,22.1,Neutropenia,16767177,6
0,22.0,Neuropathy peripheral,16767190,3
1,22.0,Trigger finger,16767190,3
2,22.0,Neuropathy peripheral,16767190,3
0,22.0,Neutropenia,16767259,6
0,22.1,Decreased appetite,16767284,6
1,22.1,Fatigue,16767284,6
2,22.1,Neoplasm progression,16767284,6
3,22.1,Diarrhoea,16767284,6
0,22.0,Photosensitivity reaction,16767304,1
1,22.0,Intertrigo,16767304,1
0,22.0,Flushing,16767336,6
1,22.0,Hyperpyrexia,16767336,1
0,22.0,White blood cell count decreased,16767355,6
1,22.0,Localised infection,16767355,3
2,22.0,Diarrhoea,16767355,6
0,22.1,Nausea,16767362,3
1,22.1,Alopecia,16767362,3
2,22.1,Hip fracture,16767362,6
3,22.1,Neoplasm progression,16767362,6
4,22.1,White blood cell count decreased,16767362,6
5,22.1,Condition aggravated,16767362,6
6,22.1,Pain,16767362,3
7,22.1,Insomnia,16767362,3
8,22.1,Decreased appetite,16767362,3
9,22.1,Feeling abnormal,16767362,6
0,22.0,Anxiety,16767370,6
1,22.0,Neoplasm progression,16767370,6
2,22.0,Platelet count decreased,16767370,6
3,22.0,Full blood count decreased,16767370,6
0,22.0,Rash,16767410,6
0,22.0,Trigger finger,16767420,3
1,22.0,Neuropathy peripheral,16767420,3
2,22.0,Neuropathy peripheral,16767420,3
0,22.0,Pyrexia,16767448,3
1,22.0,Tachycardia,16767448,3
2,22.0,Respiratory distress,16767448,5
0,22.0,No adverse event,16767449,6
0,22.1,Urinary tract infection,16767453,6
1,22.1,Aggression,16767453,6
0,22.1,Therapy cessation,16767461,
0,22.0,Death,16767506,5
0,22.0,Off label use,16767512,3
1,22.0,Therapy naive,16767512,3
2,22.0,Neurotoxicity,16767512,6
0,22.0,Febrile neutropenia,16767513,1
0,22.0,Osteonecrosis of jaw,16767514,6
1,22.0,Facial paresis,16767514,6
2,22.0,Spinal cord neoplasm,16767514,6
3,22.0,Paraparesis,16767514,6
0,22.1,Alopecia,16767535,
1,22.1,Skin exfoliation,16767535,
0,22.1,Surgery,16767540,
1,22.1,Therapy cessation,16767540,
0,22.1,Neuropathy peripheral,16767546,6
1,22.1,Metastases to peritoneum,16767546,6
2,22.1,Malignant ascites,16767546,3
3,22.1,Depression,16767546,6
4,22.1,Off label use,16767546,6
5,22.1,Xeroderma,16767546,6
6,22.1,Breast cancer metastatic,16767546,6
0,22.1,Pancreatitis acute,16767547,1
1,22.1,Nephrolithiasis,16767547,6
2,22.1,Cholelithiasis,16767547,6
3,22.1,Hepatomegaly,16767547,6
4,22.1,Diarrhoea,16767547,1
0,22.0,Pancreatitis,16767548,2
0,22.1,Dyspnoea,16767577,
1,22.1,Eye disorder,16767577,
2,22.1,Malaise,16767577,
0,22.0,Death,16767608,5
0,22.0,Hypertension,16767617,3
1,22.0,Tachycardia,16767617,1
0,22.0,Arterial thrombosis,16767618,6
1,22.0,Pneumonia aspiration,16767618,2
0,22.0,Malignant neoplasm progression,16767622,5
1,22.0,Disease progression,16767622,5
2,22.0,Fatigue,16767622,1
3,22.0,Dysgeusia,16767622,1
4,22.0,Breast cancer,16767622,5
0,22.0,Pleural effusion,16767624,6
1,22.0,Decreased immune responsiveness,16767624,6
0,22.0,Pyrexia,16767629,1
1,22.0,Chills,16767629,1
2,22.0,Lung infection,16767629,1
3,22.0,Cough,16767629,1
0,22.0,Breast cancer recurrent,16767632,6
0,22.0,Back pain,16767635,6
1,22.0,Hepatic lesion,16767635,6
2,22.0,Metastases to bone,16767635,6
0,22.0,Death,16767641,5
0,22.1,Hospitalisation,16767643,
0,22.1,Skin disorder,16767648,
1,22.1,Tooth infection,16767648,
2,22.1,Ocular hyperaemia,16767648,
3,22.1,Diarrhoea,16767648,
4,22.1,Skin discolouration,16767648,
0,22.0,Discomfort,16767649,1
1,22.0,Chest discomfort,16767649,1
0,22.0,Cardiac failure acute,16767684,2
1,22.0,Oedema peripheral,16767684,2
0,22.1,Uveitis,16767711,1
0,22.0,Back pain,16767724,6
1,22.0,Inappropriate schedule of product administration,16767724,6
2,22.0,Arthralgia,16767724,6
3,22.0,Osteonecrosis of jaw,16767724,6
0,22.0,Electrocardiogram QT prolonged,16767732,6
0,22.1,Red blood cell count decreased,16767770,1
1,22.1,Fatigue,16767770,6
2,22.1,Decreased appetite,16767770,6
3,22.1,Dry mouth,16767770,6
4,22.1,Diarrhoea,16767770,6
5,22.1,Nausea,16767770,1
6,22.1,Weight decreased,16767770,6
7,22.1,White blood cell count decreased,16767770,1
8,22.1,Bone marrow failure,16767770,2
9,22.1,Epistaxis,16767770,6
10,22.1,Platelet count decreased,16767770,1
0,22.0,Death,16767773,5
0,22.0,Gingival ulceration,16767774,1
1,22.0,Gingival pain,16767774,1
2,22.0,Pneumonia,16767774,1
3,22.0,Hypotension,16767774,1
4,22.0,Myalgia,16767774,1
5,22.0,Pyrexia,16767774,1
6,22.0,Influenza like illness,16767774,1
7,22.0,Malaise,16767774,1
8,22.0,Oropharyngeal pain,16767774,1
9,22.0,Blood pressure systolic increased,16767774,1
10,22.0,Rash,16767774,1
11,22.0,Urticaria,16767774,1
12,22.0,Ear pain,16767774,1
13,22.0,Oral pain,16767774,1
14,22.0,Parainfluenzae virus infection,16767774,1
15,22.0,Fatigue,16767774,1
16,22.0,Pain,16767774,1
17,22.0,Influenza,16767774,1
0,22.1,Respiratory tract infection,16767809,6
1,22.1,Hypocalcaemia,16767809,6
2,22.1,Haemoptysis,16767809,6
3,22.1,Hypercapnia,16767809,6
4,22.1,Cardiac failure acute,16767809,2
5,22.1,Pyrexia,16767809,6
6,22.1,Depressed level of consciousness,16767809,6
0,22.0,Neoplasm progression,16767821,6
1,22.0,Death,16767821,5
0,22.0,Oral candidiasis,16767822,2
1,22.0,Fatigue,16767822,2
2,22.0,Decreased appetite,16767822,3
3,22.0,Herpes zoster,16767822,6
4,22.0,Rash pustular,16767822,2
5,22.0,Death,16767822,5
0,22.1,Hypoalbuminaemia,16767873,2
0,22.0,Haemorrhage,16767881,6
1,22.0,Dyspnoea,16767881,6
2,22.0,Haemoglobin decreased,16767881,6
3,22.0,Death,16767881,5
4,22.0,Red blood cell count decreased,16767881,6
0,22.0,Death,16767889,5
0,22.0,Hepatic enzyme increased,16767901,6
0,22.0,Vitreous floaters,16767908,6
1,22.0,Visual impairment,16767908,3
2,22.0,Muscular weakness,16767908,6
3,22.0,Fatigue,16767908,3
4,22.0,Weight increased,16767908,3
5,22.0,Burning sensation,16767908,3
6,22.0,Bone disorder,16767908,6
7,22.0,Arthralgia,16767908,6
8,22.0,Constipation,16767908,3
9,22.0,Bladder pain,16767908,2
10,22.0,Myalgia,16767908,3
11,22.0,Amnesia,16767908,6
12,22.0,Bone pain,16767908,3
13,22.0,Vision blurred,16767908,3
14,22.0,Asthenia,16767908,3
15,22.0,Product dose omission,16767908,6
0,22.1,Muscular weakness,16767911,3
1,22.1,General physical condition abnormal,16767911,3
2,22.1,Oedema,16767911,3
3,22.1,Interstitial lung disease,16767911,5
0,22.0,Large intestine perforation,16767928,2
0,22.1,Rectal haemorrhage,16767943,2
1,22.1,Cough,16767943,3
2,22.1,Dysphagia,16767943,3
3,22.1,Oropharyngeal discomfort,16767943,6
4,22.1,Constipation,16767943,2
0,22.1,Acute hepatic failure,16767974,
0,22.0,Nausea,16768021,1
1,22.0,Vomiting,16768021,1
2,22.0,Nausea,16768021,1
3,22.0,Bone marrow failure,16768021,6
4,22.0,Vomiting,16768021,1
0,22.0,Abdominal pain lower,16768032,6
1,22.0,Appendiceal abscess,16768032,1
2,22.0,Appendicitis perforated,16768032,1
0,22.0,Mobility decreased,16768060,6
1,22.0,Musculoskeletal pain,16768060,6
0,22.0,Folate deficiency,16768063,6
0,22.0,Folate deficiency,16768066,6
0,22.1,Dizziness,16768069,3
1,22.1,Fatigue,16768069,6
2,22.1,Diplopia,16768069,6
3,22.1,Visual impairment,16768069,6
4,22.1,"Hallucination, visual",16768069,1
5,22.1,Respiratory rate increased,16768069,3
6,22.1,Dyspnoea,16768069,3
0,22.0,Bone pain,16768071,6
1,22.0,Deafness,16768071,6
2,22.0,Pruritus,16768071,6
0,22.0,Malaise,16768084,2
1,22.0,Hyperglycaemia,16768084,2
0,22.1,Skin discolouration,16768115,
1,22.1,Diarrhoea,16768115,
2,22.1,Tooth extraction,16768115,
3,22.1,Tooth infection,16768115,
0,22.0,Hepatotoxicity,16768146,3
1,22.0,Cardio-respiratory arrest,16768146,5
0,22.1,Blood count abnormal,16768156,6
1,22.1,Dementia,16768156,6
2,22.1,Gait disturbance,16768156,6
3,22.1,Type 1 diabetes mellitus,16768156,6
4,22.1,Aphasia,16768156,6
5,22.1,Speech disorder,16768156,6
6,22.1,Asthenia,16768156,6
7,22.1,Platelet count decreased,16768156,6
8,22.1,Feeling cold,16768156,3
9,22.1,Pruritus,16768156,3
10,22.1,Head discomfort,16768156,6
11,22.1,Anal incontinence,16768156,6
12,22.1,Hallucination,16768156,6
13,22.1,Urinary tract infection,16768156,6
14,22.1,Confusional state,16768156,6
15,22.1,Amnesia,16768156,3
16,22.1,Pain of skin,16768156,6
17,22.1,Encephalitis autoimmune,16768156,6
18,22.1,Dysstasia,16768156,6
19,22.1,Screaming,16768156,3
20,22.1,Urinary incontinence,16768156,6
0,22.1,Influenza like illness,16768157,
1,22.1,Pain in extremity,16768157,
2,22.1,Gait disturbance,16768157,
3,22.1,Movement disorder,16768157,
4,22.1,Joint swelling,16768157,
5,22.1,Paraesthesia,16768157,
6,22.1,Pain,16768157,
0,22.0,Hypertensive urgency,16768178,3
1,22.0,Drug intolerance,16768178,6
2,22.0,Visual impairment,16768178,3
3,22.0,Bowel movement irregularity,16768178,3
4,22.0,Onychoclasis,16768178,3
5,22.0,Hypotension,16768178,3
6,22.0,Cough,16768178,3
7,22.0,Headache,16768178,3
8,22.0,Dyspnoea,16768178,3
9,22.0,Nausea,16768178,3
10,22.0,Somnolence,16768178,3
11,22.0,Abdominal discomfort,16768178,3
12,22.0,Dizziness,16768178,3
13,22.0,Polyneuropathy,16768178,3
14,22.0,Heart rate irregular,16768178,3
15,22.0,Tremor,16768178,3
16,22.0,Breast pain,16768178,3
17,22.0,Bone pain,16768178,3
18,22.0,Myalgia,16768178,3
0,22.1,Product label issue,16768212,6
1,22.1,Prostatic specific antigen increased,16768212,6
2,22.1,Prostatic specific antigen increased,16768212,6
0,22.0,Infection,16768221,6
0,22.1,Disease progression,16768233,
0,22.0,Dermatomyositis,16768262,6
0,22.0,Metastases to lymph nodes,16768265,3
0,22.0,Thrombocytopenia,16768266,6
1,22.0,Cardiac ventricular thrombosis,16768266,6
2,22.0,Embolic stroke,16768266,6
0,22.0,Cough,16768271,6
1,22.0,Weight decreased,16768271,6
2,22.0,Metastases to bone,16768271,6
3,22.0,Lymphadenopathy mediastinal,16768271,6
4,22.0,Malignant neoplasm progression,16768271,6
5,22.0,Diarrhoea,16768271,6
0,22.1,Rhabdomyolysis,16768279,3
0,22.0,Death,16768307,5
0,22.0,Dyspnoea,16768330,6
1,22.0,Pyrexia,16768330,6
2,22.0,Idiopathic pulmonary fibrosis,16768330,6
0,22.0,Infusion site extravasation,16768331,1
0,22.1,Metastases to spleen,16768375,6
1,22.1,Endometrial cancer,16768375,5
2,22.1,Metastases to lymph nodes,16768375,6
3,22.1,Malignant neoplasm progression,16768375,5
4,22.1,Nausea,16768375,6
5,22.1,Pain,16768375,6
6,22.1,Metastases to liver,16768375,6
7,22.1,Vomiting,16768375,6
8,22.1,Malignant ascites,16768375,6
0,22.0,Death,16768390,5
1,22.0,Malignant neoplasm progression,16768390,6
0,22.0,Hyperhidrosis,16768405,1
1,22.0,Dyspnoea at rest,16768405,1
2,22.0,Chest pain,16768405,1
3,22.0,Vomiting,16768405,1
4,22.0,Feeling hot,16768405,1
0,22.0,Depression,16768409,6
1,22.0,Weight increased,16768409,6
2,22.0,Hypokinesia,16768409,6
3,22.0,Fall,16768409,6
4,22.0,Feeling abnormal,16768409,6
5,22.0,Radius fracture,16768409,6
0,22.0,Hepatocellular injury,16768483,1
1,22.0,Drug interaction,16768483,6
0,22.0,Product use in unapproved indication,16768519,6
1,22.0,Blood creatinine increased,16768519,6
2,22.0,Septic shock,16768519,5
3,22.0,Vomiting,16768519,6
0,22.0,Malignant neoplasm progression,16768563,6
1,22.0,Drug resistance,16768563,6
0,22.0,Coma,16768585,5
1,22.0,Respiratory tract infection,16768585,5
0,22.0,Sepsis,16768622,5
0,22.1,Death,16768642,5
0,22.0,Alopecia,16768868,2
0,22.1,Alopecia,16768883,2
0,22.0,Vomiting,16768954,6
1,22.0,Product use in unapproved indication,16768954,6
0,22.0,Product use in unapproved indication,16768958,6
1,22.0,Disease progression,16768958,3
0,22.0,Diarrhoea,16768987,1
1,22.0,Off label use,16768987,3
2,22.0,Product use in unapproved indication,16768987,3
0,22.0,Rash,16768990,6
1,22.0,Product use in unapproved indication,16768990,6
0,22.1,Rash,16768992,6
1,22.1,Product use in unapproved indication,16768992,6
0,22.0,Haemoglobin decreased,16768993,6
1,22.0,Product use in unapproved indication,16768993,6
2,22.0,Nausea,16768993,6
3,22.0,Vomiting,16768993,6
0,22.0,Swelling of eyelid,16768999,6
1,22.0,Product use in unapproved indication,16768999,6
2,22.0,Product dose omission,16768999,6
3,22.0,Rash,16768999,6
4,22.0,Dermatitis acneiform,16768999,6
5,22.0,Paronychia,16768999,6
0,22.1,Product use in unapproved indication,16769000,6
1,22.1,Constipation,16769000,6
2,22.1,Product odour abnormal,16769000,6
3,22.1,Rash,16769000,3
0,22.0,Product use in unapproved indication,16769006,6
1,22.0,Disease progression,16769006,5
0,22.0,Product use in unapproved indication,16769019,6
1,22.0,Fatigue,16769019,6
2,22.0,Alopecia,16769019,6
3,22.0,Rash,16769019,6
0,22.0,Toxicity to various agents,16769030,6
1,22.0,Product use in unapproved indication,16769030,6
0,22.0,Product use in unapproved indication,16769037,6
1,22.0,Nausea,16769037,6
0,22.0,Vomiting,16769040,6
1,22.0,Product use in unapproved indication,16769040,6
2,22.0,Rash,16769040,6
3,22.0,Hypersensitivity,16769040,6
4,22.0,Lip swelling,16769040,6
5,22.0,Nausea,16769040,6
6,22.0,Constipation,16769040,6
7,22.0,Pyrexia,16769040,6
8,22.0,Abdominal pain upper,16769040,6
9,22.0,Eye swelling,16769040,6
10,22.0,Alopecia,16769040,6
11,22.0,Fatigue,16769040,6
0,22.1,Off label use,16769044,6
1,22.1,Weight decreased,16769044,6
2,22.1,Diarrhoea,16769044,6
3,22.1,Decreased appetite,16769044,6
0,22.1,Skin atrophy,16769045,3
1,22.1,Nausea,16769045,3
2,22.1,Acne,16769045,3
3,22.1,Product use in unapproved indication,16769045,6
0,22.0,Product use in unapproved indication,16769047,6
1,22.0,Diarrhoea,16769047,3
2,22.0,Peripheral swelling,16769047,6
3,22.0,Unevaluable event,16769047,6
0,22.0,Product use in unapproved indication,16769048,6
1,22.0,Adverse event,16769048,6
0,22.1,Product use in unapproved indication,16769051,6
1,22.1,Diarrhoea,16769051,3
2,22.1,Death,16769051,5
3,22.1,Constipation,16769051,3
4,22.1,Nausea,16769051,3
0,22.0,Insomnia,16769052,6
1,22.0,Product use in unapproved indication,16769052,6
0,22.0,Disease progression,16769055,6
1,22.0,Product use in unapproved indication,16769055,6
0,22.1,Alopecia,16769061,2
1,22.1,Psychological trauma,16769061,6
0,22.1,Product use in unapproved indication,16769063,6
1,22.1,Abdominal pain upper,16769063,6
2,22.1,Vomiting,16769063,6
3,22.1,Dyspnoea,16769063,3
4,22.1,Rash pruritic,16769063,6
0,22.0,Product use in unapproved indication,16769064,6
1,22.0,Visual impairment,16769064,6
0,22.0,Malaise,16769089,6
1,22.0,Product use in unapproved indication,16769089,6
2,22.0,Nausea,16769089,6
3,22.0,Fatigue,16769089,6
0,22.0,Metastasis,16769096,6
1,22.0,Hypertension,16769096,6
0,22.0,Product use in unapproved indication,16769102,6
1,22.0,Gastrointestinal ulcer,16769102,3
0,22.0,Nausea,16769104,6
1,22.0,Product use in unapproved indication,16769104,6
0,22.0,Asthenia,16769109,3
1,22.0,Product use in unapproved indication,16769109,6
0,22.0,Neuropathy peripheral,16769110,3
1,22.0,Product use in unapproved indication,16769110,3
0,22.1,Blood glucose increased,16769111,3
1,22.1,Product use in unapproved indication,16769111,6
2,22.1,Disease progression,16769111,6
0,22.0,Product use in unapproved indication,16769116,6
1,22.0,Vitreous floaters,16769116,3
2,22.0,Vision blurred,16769116,3
3,22.0,Abdominal pain,16769116,3
4,22.0,Eye pain,16769116,1
0,22.0,Death,16769140,5
0,22.0,Aspartate aminotransferase increased,16769169,6
1,22.0,Hepatic steatosis,16769169,6
2,22.0,Alanine aminotransferase increased,16769169,6
3,22.0,Off label use,16769169,6
0,22.0,Bone marrow failure,16769198,6
0,22.0,Cardiac failure chronic,16769212,6
1,22.0,Lymphadenopathy mediastinal,16769212,6
2,22.0,Ventricular tachycardia,16769212,6
3,22.0,Inappropriate schedule of product administration,16769212,6
4,22.0,Left ventricular dysfunction,16769212,3
5,22.0,Drug intolerance,16769212,6
6,22.0,Pleural effusion,16769212,6
7,22.0,Autoimmune myocarditis,16769212,4
8,22.0,Cardiac failure,16769212,6
9,22.0,Congestive cardiomyopathy,16769212,4
10,22.0,Off label use,16769212,6
11,22.0,Performance status decreased,16769212,6
0,22.0,Off label use,16769249,6
0,22.0,Decreased appetite,16769329,3
1,22.0,Intra-abdominal fluid collection,16769329,3
2,22.0,Bacteraemia,16769329,3
3,22.0,Nausea,16769329,3
4,22.0,Abdominal distension,16769329,3
5,22.0,Blood pressure increased,16769329,3
6,22.0,Fatigue,16769329,3
7,22.0,Cough,16769329,3
0,22.0,Diarrhoea,16769340,1
1,22.0,Nausea,16769340,1
2,22.0,Fatigue,16769340,1
3,22.0,Weight decreased,16769340,1
4,22.0,Anaemia,16769340,6
5,22.0,Decreased appetite,16769340,1
6,22.0,Neutropenia,16769340,6
7,22.0,Back pain,16769340,1
0,22.1,Diarrhoea,16769370,1
0,22.0,Death,16769382,5
0,22.0,Thrombocytopenia,16769383,1
0,22.0,Off label use,16769392,6
1,22.0,Malignant neoplasm progression,16769392,5
0,22.0,Ill-defined disorder,16769393,5
0,22.1,Hypercalcaemia,16769408,1
1,22.1,Hyponatraemia,16769408,1
2,22.1,Hyperkalaemia,16769408,1
3,22.1,Decreased appetite,16769408,1
0,22.0,Blood iron decreased,16769429,6
1,22.0,Product use in unapproved indication,16769429,6
0,22.0,Pancreatitis,16769438,6
1,22.0,Coeliac disease,16769438,2
2,22.0,Hypothyroidism,16769438,6
0,22.0,Mucosal inflammation,16769449,6
0,22.1,Device failure,16769512,6
0,22.0,Influenza,16769594,2
1,22.0,Bladder operation,16769594,1
0,22.0,Paronychia,16769601,6
1,22.0,Drug resistance,16769601,6
2,22.0,Malignant neoplasm progression,16769601,6
0,22.0,Conjunctivitis,16769618,3
1,22.0,Malignant neoplasm progression,16769618,5
0,22.0,Metastases to meninges,16769619,6
0,22.0,Death,16769654,5
0,22.0,Cachexia,16769725,6
1,22.0,Vomiting,16769725,6
2,22.0,Off label use,16769725,6
3,22.0,Dizziness,16769725,6
4,22.0,Decreased appetite,16769725,6
5,22.0,Nausea,16769725,6
0,22.1,Febrile neutropenia,16769732,1
1,22.1,Colony stimulating factor therapy,16769732,1
2,22.1,Interstitial lung disease,16769732,2
3,22.1,Febrile neutropenia,16769732,1
0,22.0,Pallor,16769750,3
1,22.0,Myalgia,16769750,3
2,22.0,Asthenia,16769750,3
3,22.0,Dehydration,16769750,1
0,22.0,General physical health deterioration,16769780,5
1,22.0,Neuropathy peripheral,16769780,6
2,22.0,Renal failure,16769780,5
0,22.0,Candida infection,16769815,6
1,22.0,Cough,16769815,6
2,22.0,Diarrhoea,16769815,6
3,22.0,Asthenia,16769815,6
4,22.0,Breast cancer recurrent,16769815,6
5,22.0,Pain,16769815,6
6,22.0,Pleural effusion,16769815,6
7,22.0,Interstitial lung disease,16769815,6
8,22.0,Vulvovaginal mycotic infection,16769815,6
9,22.0,Influenza,16769815,6
10,22.0,Rhonchi,16769815,6
11,22.0,Pyrexia,16769815,6
12,22.0,Decreased appetite,16769815,6
13,22.0,Pneumonia,16769815,6
14,22.0,Bronchitis,16769815,1
15,22.0,Dyspnoea,16769815,6
16,22.0,Nausea,16769815,6
17,22.0,General physical health deterioration,16769815,6
0,22.1,Immune-mediated adverse reaction,16769829,3
1,22.1,Systemic immune activation,16769829,1
2,22.1,Immunisation reaction,16769829,1
0,22.0,Hyperammonaemia,16769840,1
1,22.0,Status epilepticus,16769840,1
2,22.0,Encephalopathy,16769840,1
0,22.1,Adverse drug reaction,16769885,6
1,22.1,Hypotension,16769885,6
2,22.1,Hypomagnesaemia,16769885,6
3,22.1,Rhinitis,16769885,6
4,22.1,Rash pruritic,16769885,6
5,22.1,Pyrexia,16769885,6
6,22.1,Oropharyngeal pain,16769885,6
7,22.1,Hypocalcaemia,16769885,6
8,22.1,Proteinuria,16769885,6
9,22.1,Anaemia,16769885,6
10,22.1,Hypertension,16769885,6
11,22.1,Vitamin D decreased,16769885,6
12,22.1,Rash,16769885,6
13,22.1,Neuropathy peripheral,16769885,6
14,22.1,Abscess drainage,16769885,6
0,22.0,Pneumonia,16769892,5
0,22.0,Thrombosis,16769907,6
1,22.0,Acute myocardial infarction,16769907,6
0,22.0,Bradycardia,16769945,6
0,22.1,Blood urine present,16769953,3
1,22.1,Urinary tract infection,16769953,2
2,22.1,Accidental exposure to product,16769953,6
3,22.1,Diarrhoea,16769953,3
4,22.1,Device malfunction,16769953,6
5,22.1,Vomiting,16769953,3
6,22.1,Skin reaction,16769953,3
7,22.1,Catheter site rash,16769953,2
8,22.1,Dizziness,16769953,3
9,22.1,Therapeutic embolisation,16769953,2
0,22.1,Breast cancer,16769969,6
0,22.0,Asthma,16770008,1
0,22.1,Cell death,16770009,1
1,22.1,Transaminases abnormal,16770009,1
0,22.1,Bladder cancer recurrent,16770049,6
0,22.0,Interstitial lung disease,16770063,3
1,22.0,Infusion related reaction,16770063,3
2,22.0,Death,16770063,5
3,22.0,Blood creatine phosphokinase increased,16770063,6
4,22.0,Blood sodium increased,16770063,6
0,22.0,Mass,16770070,5
0,22.0,Adverse event,16770117,6
0,22.0,Headache,16770142,1
1,22.0,Abdominal pain,16770142,1
2,22.0,Urinary tract infection,16770142,3
3,22.0,Pain in extremity,16770142,1
0,22.1,Loss of consciousness,16770160,1
1,22.1,Muscular weakness,16770160,6
2,22.1,Decreased appetite,16770160,3
3,22.1,Anaemia,16770160,6
4,22.1,Loss of consciousness,16770160,6
5,22.1,Transfusion,16770160,6
6,22.1,Feeling abnormal,16770160,6
7,22.1,Fall,16770160,6
8,22.1,Urinary tract infection,16770160,1
9,22.1,Head injury,16770160,6
10,22.1,Liver function test increased,16770160,3
11,22.1,Carbohydrate antigen 125 increased,16770160,6
12,22.1,Constipation,16770160,1
13,22.1,Dizziness,16770160,3
0,22.1,Leukopenia,16770177,3
1,22.1,Hot flush,16770177,3
2,22.1,Burning sensation,16770177,3
3,22.1,Nausea,16770177,3
4,22.1,Hypocalcaemia,16770177,3
5,22.1,Alopecia,16770177,3
6,22.1,Fatigue,16770177,3
0,22.0,Malignant neoplasm progression,16770191,6
1,22.0,Drug resistance,16770191,6
0,22.1,Cystitis,16770203,5
1,22.1,Blood potassium increased,16770203,6
2,22.1,Prostate cancer,16770203,5
0,22.0,Urinary tract infection,16770236,6
0,22.0,Peripheral artery occlusion,16770257,3
0,22.0,Disease progression,16770299,6
1,22.0,Drug resistance,16770299,6
0,22.0,Drug resistance,16770300,6
1,22.0,Malignant neoplasm progression,16770300,6
0,22.0,Gastrointestinal disorder,16770303,6
1,22.0,Alopecia,16770303,6
2,22.0,Nephropathy toxic,16770303,6
3,22.0,Neurotoxicity,16770303,6
4,22.0,Diarrhoea,16770303,6
5,22.0,Hepatotoxicity,16770303,6
6,22.0,Bone marrow failure,16770303,6
7,22.0,Abdominal pain,16770303,6
0,22.0,Pneumatosis intestinalis,16770389,6
1,22.0,Pneumoperitoneum,16770389,6
0,22.0,Respiratory failure,16770403,5
1,22.0,Off label use,16770403,6
2,22.0,Haematochezia,16770403,6
3,22.0,Haemoglobin decreased,16770403,6
4,22.0,Intentional product use issue,16770403,6
5,22.0,Fatigue,16770403,6
0,22.0,Endocarditis,16770442,3
1,22.0,Peripheral ischaemia,16770442,3
2,22.0,Peripheral embolism,16770442,3
0,22.0,Wound infection,16770511,6
0,22.0,Cardiac dysfunction,16770567,6
0,22.0,Cardiac dysfunction,16770568,6
0,22.0,Cardiac dysfunction,16770569,6
0,22.1,Decreased appetite,16770644,6
1,22.1,Full blood count decreased,16770644,6
2,22.1,Neuropathy peripheral,16770644,3
3,22.1,Fatigue,16770644,3
0,22.0,Ischaemic stroke,16770648,2
0,22.0,Nausea,16770650,6
1,22.0,Diarrhoea,16770650,6
2,22.0,Vomiting,16770650,6
0,22.0,Ocular neoplasm,16770672,6
1,22.0,Sinusitis,16770672,1
0,22.0,Tumour lysis syndrome,16770673,2
1,22.0,Renal failure,16770673,2
2,22.0,Cardiac arrest,16770673,1
3,22.0,Pathological fracture,16770673,6
4,22.0,Coronary artery disease,16770673,2
0,22.0,Aortic thrombosis,16770703,6
1,22.0,Weight bearing difficulty,16770703,6
2,22.0,Drug intolerance,16770703,6
3,22.0,Hypoaesthesia,16770703,6
4,22.0,Paraesthesia,16770703,6
5,22.0,Off label use,16770703,6
6,22.0,Gait disturbance,16770703,6
0,22.0,Drug resistance,16770727,6
1,22.0,Malignant neoplasm progression,16770727,6
0,22.0,Malignant neoplasm progression,16770736,6
1,22.0,Drug resistance,16770736,6
2,22.0,Weight decreased,16770736,6
0,22.0,Death,16770737,5
0,22.0,Malignant neoplasm progression,16770757,5
0,22.0,Weight decreased,16770767,6
1,22.0,Hypertensive crisis,16770767,1
2,22.0,Diarrhoea,16770767,3
0,22.0,Mitral valve incompetence,16770785,6
